MedTrace Logo

Autologous Bone Marrow Stem Cells in Pressure Ulcer Treatment

NCT01572376 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-08-25

No results posted yet for this study

Summary

The aim of the study is to determine the safety and feasibility of an autologous mononuclear stem cells infusion in pressure ulcers of paraplegic patients; and moreover, to evaluate the efficacy of the treatment.

Conditions

  • Type IV Pressure Ulcers
  • Chronic Wounds
  • Spinal Cord Injury

Interventions

PROCEDURE

Infusion of autologous bone marrow stem cells after wound debridement.

Cleaning of the wound with heparinized saline, cell infusion and closing with suture.

Sponsors & Collaborators

  • Hospital Universitario Central de Asturias

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-12-31
Completion
2010-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01572376 on ClinicalTrials.gov